🟠 Moderate Evidence
Copper and iron metabolism are metabolically linked in ways that standard clinical practice often overlooks. Iron cannot circulate or be utilised without copper-dependent enzymes acting as gatekeepers at critical checkpoints in absorption, transport, and recycling—yet copper deficiency is rarely investigated in patients with refractory anemia. A case series published in clinical literature documented five patients initially suspected of having myelodysplastic syndrome whose anaemia and neutropenia fully resolved following copper supplementation, highlighting a diagnosis that can elude clinicians for months or years when copper is absent from standard diagnostic workups.
Key takeaways
- Iron transport depends on three copper-dependent enzymes—hephaestin, ceruloplasmin, and GPI-ceruloplasmin—that control iron movement at absorption, circulation, and recycling stages
- Copper deficiency creates a paradox: iron accumulates in storage tissues while bone marrow remains iron-starved, producing anaemia that mimics true iron deficiency on standard blood tests
- Prescribing additional iron to copper-deficient patients increases free radical damage without correcting anaemia, potentially worsening oxidative injury in tissues where iron becomes trapped
- Bariatric surgery is the most common cause of copper deficiency, yet copper screening is not routine in post-surgical populations with unexplained anaemia
Three copper gates control iron’s journey through the body
The relationship between copper and iron is fundamentally enzymatic. When dietary iron enters intestinal cells (enterocytes), it cannot exit into the bloodstream without hephaestin, a ferroxidase enzyme embedded in the cell membrane that is copper-dependent. Once iron enters the circulation, it must be oxidized from its reduced form (Fe²⁺) to its oxidized form (Fe³⁺) by ceruloplasmin, a second copper enzyme, before it can bind transferrin and travel to the bone marrow for haemoglobin synthesis. A third copper-dependent checkpoint occurs when macrophages break down aged red blood cells: the recycled iron requires GPI-anchored ceruloplasmin to re-enter circulation. All three gates require functional copper enzymes.
The Three Copper-Dependent Checkpoints in Iron Metabolism
Iron transport requires copper-dependent enzymes at absorption, circulation, and recycling stages
Enzymatic requirement for iron transport | Georgian Medical Journal News
Copper deficiency traps iron, mimicking iron deficiency anaemia
When copper levels fall, iron does not disappear from the body—it accumulates in the wrong tissues. Preclinical research in copper-deficient animal models demonstrates hepatic and intestinal iron overload while simultaneously producing anaemia of microcytic, hypochromic morphology—the same presentation as true iron deficiency on a complete blood count (CBC). The critical distinction is biochemical: iron is sequestered in storage tissues in its reactive Fe²⁺ form, where it cannot be mobilised to the bone marrow.
This creates a diagnostic trap. Clinicians observing microcytic, hypochromic anaemia reflexively prescribe iron supplementation. But if copper is the rate-limiting factor, additional iron will not reach the bone marrow. Instead, it accumulates further in tissues already laden with iron, increasing free radical production through Fenton chemistry—the chemical mechanism by which free Fe²⁺ generates hydroxyl radicals. The patient’s anaemia persists, and oxidative tissue damage worsens.
Clinical cases reveal months of diagnostic delay
A case series documented by researchers identified five patients referred with suspected myelodysplastic syndrome (a bone marrow malignancy) who presented with both anaemia and neutropenia—conditions that normally suggest haematopoietic failure. Routine investigations found normal bone marrow morphology but raised clinical suspicion. Serum copper and ceruloplasmin testing, performed only as part of extended nutritional screening, revealed severe copper deficiency in all five patients. Copper supplementation alone resolved both the anaemia and neutropenia in every case. The diagnostic journey—from referral for suspected cancer to resolution with a trace mineral—took months to years because copper had not been included in initial workups.
Five patients initially suspected of myelodysplastic syndrome had anaemia and neutropenia that fully resolved with copper supplementation, demonstrating that copper deficiency can masquerade as bone marrow failure when serum copper is not measured.
— Clinical case series documentation (unpublished case records cited in nutritional biochemistry literature)
Post-bariatric surgery patients carry highest risk
Bariatric surgery is the most common cause of copper deficiency, affecting approximately half of post-surgical patients, according to published epidemiological assessments of micronutrient absorption following gastric bypass and related procedures. The surgically altered anatomy reduces copper absorption—both through reduced gastric acid production needed to solubilise copper and through bypassed segments of small bowel. Yet routine post-bariatric monitoring focuses on iron, vitamin B12, and vitamin D; copper screening is rarely standard practice.
Post-bariatric patients who develop anaemia unresponsive to iron supplementation are at particular risk of diagnostic delay. Copper testing is not part of standard post-operative surveillance protocols, meaning the biochemical cause remains masked. Clinicians should consider copper screening in bariatric patients with persistent anaemia, alongside standard iron indices.
What this means
Frequently asked questions
Can I have copper deficiency if my iron levels look normal?
Yes. Copper deficiency causes iron to accumulate in storage tissues (liver, intestines) while bone marrow iron-stores may appear depleted on testing. Standard iron indices—serum iron, ferritin, and transferrin saturation—may show a mixed or confusing picture. Serum copper and ceruloplasmin testing are required to unmask the true diagnosis.
Why don’t doctors test for copper routinely?
Copper deficiency is rare in the general population consuming varied diets. It became clinically recognisable only after bariatric surgery became common, and post-operative protocols have not yet universally incorporated copper screening. Additionally, the copper–iron interaction is biochemically complex and not part of standard medical school curricula, so clinicians may not consider it in differential diagnosis.
How much copper supplementation is needed to correct anaemia?
Dosing depends on baseline serum copper level and clinical context, but typical replacement ranges from 2–8 mg daily in divided doses. Patients with documented copper deficiency should be managed by a physician; self-supplementation risks copper toxicity. Response to therapy—normalisation of ceruloplasmin and resolution of anaemia—should be monitored with repeat serum copper and ceruloplasmin testing 4–8 weeks after initiation.
As awareness of copper’s critical role in iron metabolism grows, so should vigilance for this diagnosis in at-risk populations. Bariatric patients, those with malabsorptive disorders, and patients with anaemia unresponsive to iron therapy deserve copper testing as part of their standard workup. The convergence of biochemical precision and clinical outcome—anaemia resolving with a single mineral—offers a powerful reminder that metabolic bottlenecks, not absolute mineral absence, often drive disease.
Source: Copper and iron metabolism: enzymatic interdependence
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
